Although the overexpression of TKTL1 takes also place in carcinomas [16], sarcomas [13], glioblastomas [26], lymphomas [27], and leukemias, the percentage of tumors overexpressing TKTL1 is lower compared to Apo10. This evidence concerns the gene TKTL1 and glioblastoma.